Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

NEOGAP Therapeutics AB

Closing information (x1000 DKK)

Closing information 2023/12 2022/12 2021/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 162 More Arrow 852 More Arrow 1,018
Earnings before taxes -7,687 Less Arrow -40,451 More Arrow -7,350
EBITDA -3,664 More Arrow -1,721 Less Arrow -6,522
Total assets 82,049 Less Arrow 42,480 More Arrow 90,494
Current assets 37,684 Less Arrow 16,742 More Arrow 35,882
Current liabilities 13,507 Less Arrow 2,739 More Arrow 3,234
Equity capital 32,608 Less Arrow 3,991 More Arrow 48,359
- share capital 89 Less Arrow 53 Less Arrow 36
Employees (average) 14 Equal arrow 14 Less Arrow 13

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 39.7% Less Arrow 9.4% More Arrow 53.4%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -9.2% Less Arrow -93.2% More Arrow -7.0%
Current ratio 279.0% More Arrow 611.2% More Arrow 1109.5%
Return on equity (ROE) -23.6% Less Arrow -1013.6% More Arrow -15.2%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 0 More Arrow 1 More Arrow 3
Chg. No. of employees % 0% More Arrow 8% More Arrow 30%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.